Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(10)
Chromosomal Abnormalities
Coenzyme Q
Comet Assay
Controlled Trial
Down Syndrome
Genetics
Oxidant Stress
Oxidative Dna Damage
Randomized Controlled Trial
Single Cell Gel Electrophoresis
Subscribe
Academic
Publications
Effect of Coenzyme Q 10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial
Effect of Coenzyme Q 10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial,10.1016/j.neurobiolag
Edit
Effect of Coenzyme Q 10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial
(
Citations: 1
)
BibTex
|
RIS
|
RefWorks
Download
L. Tiano
,
P. Carnevali
,
L. Padella
,
L. Santoro
,
F. Principi
,
F. Brugè
,
F. Carle
,
R. Gesuita
,
O. Gabrielli
,
G. P. Littarru
Down syndrome
(DS) is a chromosomal abnormality (trisomy 21) associated with a complex phenotype. Oxidative stress is known to play a major role in this pathology both due to genetic and epigenetic factors, suggesting that oxidative imbalance contributes to the clinical manifestation of DS. In particular, the implications of
oxidative DNA damage
in
Down syndrome
has been linked with neurodegeneration. Here we report the results of a double blind
controlled trial
aimed at investigating the protective effect of Coenzyme Q10 on DNA oxidation in this clinical setting using the
single cell gel electrophoresis
technique.
Journal:
Neurobiology of Aging - NEUROBIOL AGING
, vol. 32, no. 11, pp. 2103-2105, 2011
DOI:
10.1016/j.neurobiolaging.2009.11.016
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
www.sciencedirect.com
)
(
linkinghub.elsevier.com
)
References
(9)
Down Syndrome: Advances in Molecular Biology and the Neurosciences
(
Citations: 24
)
GEORGE T. CAPONE
The comet assay: topical issues
(
Citations: 103
)
Andrew R. Collins
,
Amaia Azqueta Oscoz
,
Gunnar Brunborg
,
I. Gaivao
,
Lisa Giovannelli
,
Marcin Kruszewski
,
Catherine C. Smith
,
R. Stetina
Journal:
Mutagenesis
, vol. 23, no. 3, pp. 143-151, 2008
Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis and single-cell gel electrophoresis
(
Citations: 31
)
Sharbel Weidner Maluf
,
Bernardo Erdtmann
Journal:
Cancer Genetics and Cytogenetics - CANCER GENET CYTOGENET
, vol. 124, no. 1, pp. 71-75, 2001
Coenzyme Q10 (Ubiquinol-10) Supplementation Improves Oxidative Imbalance in Children With Trisomy 21
(
Citations: 6
)
Michael V. Miles
,
Bonnie J. Patterson
,
Melinda L. Chalfonte-Evans
,
Paul S. Horn
,
Francis J. Hickey
,
Mark B. Schapiro
,
Paul E. Steele
,
Peter H. Tang
,
Stephanie L. Hotze
Journal:
Pediatric Neurology - PEDIAT NEUROL
, vol. 37, no. 6, pp. 398-403, 2007
Mental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms
(
Citations: 17
)
Mohammed Rachidi
,
Carmela Lopes
Journal:
Neuroscience Research - NEUROSCI RES
, vol. 59, no. 4, pp. 349-369, 2007
Sort by:
Citations
(1)
Day Sleepiness Linked to Poor Drug Adherence
Bruce Jancin
Journal:
Internal Medicine News
, vol. 43, no. 15, pp. 19-19, 2010